Next, we evaluated the spectrum (A:T > C:G, A:T > G:C, A:T > T:A, G:C > A:T, G:C > C:G, G:C > T:A, and deletion type) of TP53 mutations detected in Rwandan patients with gastric cancer (Fig. 4 and supplementary Table S2). This evidence concerns the gene TP53 and gastric cancer.